Ticker

PTGX

Protagonist Therapeutics, Inc

7 catalysts on file

PTGX

Protagonist Therapeutics, Inc

Approval Confirmed

ICOTYDE

moderate-to-severe plaque psoriasis

111d ago Mar 18, 2026

SEC 8-K verified 14h ago

Countdown card →

PTGX

Protagonist Therapeutics, Inc

Phase 2 AI-extracted

ICOTYDE

plaque psoriasis

97d ago Apr 1, 2026

SEC 8-K verified 14h ago

Countdown card →

PTGX

Protagonist Therapeutics, Inc

Phase 1 AI-extracted

PN-881

7d ago Jun 30, 2026

SEC 8-K verified 14h ago

Countdown card →

PTGX

Protagonist Therapeutics, Inc

PDUFA AI-extracted

rusfertide

polycythemia vera

T-minus 55 days Aug 31, 2026

SEC 8-K verified 14h ago

Countdown card →

PTGX

Protagonist Therapeutics, Inc

Phase 1 AI-extracted

PN-477

T-minus 208 days Jan 31, 2027

SEC 8-K verified 14h ago

Countdown card →

PTGX

Protagonist Therapeutics, Inc

Phase 3 AI-extracted

ICOTYDE

psoriatic arthritis, ulcerative colitis, Crohn’s disease

Date TBD Date TBD

SEC 8-K verified 14h ago

Countdown card →

PTGX

Protagonist Therapeutics, Inc

PDUFA AI-extracted

ICOTYDE

plaque psoriasis

Date TBD Date TBD

SEC 8-K verified 14h ago

Countdown card →